Tyler Flores

In a powerful move, Ashkenazy Acquisition Corp. acquires a major Chicago retail center, part of a $750M spree that defies market doomsayers.

A legal fight over attorney fees in the Hess-Chevron deal reveals a costly risk in M&A. Here's why healthcare execs and investors should pay attention.

A shareholder lawsuit challenges Comerica's $10.9B sale to Fifth Third, citing a rushed process, CEO self-interest, and an undervalued price.

A monumental $31.5 billion contract tasks Peraton with replacing the FAA's aging air traffic control system. Can it succeed where others have failed?

Gartner's inaugural 4PL Magic Quadrant names Redwood a Visionary, highlighting how tech-driven logistics are reshaping healthcare supply chain resilience.

A breakthrough in Houston: Tiny microbes are eating methane waste and turning it into valuable fertilizer, offering a profitable solution to climate change.

With royal backing, global financiers are vowing to unleash trillions for sustainable growth in emerging markets. Is this a real turning point or just talk?

A landmark Miami skyscraper's leasing boom, led by a longevity clinic, reveals how strategic upgrades and market diversification are reshaping Sunbelt cities.

As regulations tighten, ACT's new power solution aims to cut diesel use in refrigerated transport, a critical move for the global pharma supply chain.

As banks retreat from commercial real estate, Nuveen's oversubscribed debt fund signals a major shift toward alternative lenders in the value-add space.

Amid global headwinds, PE firms deploy innovative strategies to fuel deals, with a major focus on healthcare and technology as the market slowly recovers.

As AI and connected devices transform medicine, a vast, unsecured digital workforce has emerged. Discover why securing machine identities is now critical.

Commuters face five years of toll hikes for bridge repairs. This necessary investment sparks debate on affordability and the future of Bay Area travel.

A perfect storm of provider fee waivers and new tax credits is finally making 401(k)s affordable for small businesses, reshaping the battle for talent.

China's Tsinghua University unveils a landmark AI framework for education, setting a new global standard and shaping the next generation of innovators.

A potent pancreatic cancer drug shows promise as a second-line therapy for advanced biliary tract cancer, balancing improved survival with major toxicity.

European digital asset giant CoinShares is going public in the US via a SPAC, a move that tests the waters for institutional crypto in a new regulatory era.

A massive federal investment is kickstarting a tech revolution in airport screening. AI, biometrics, and new players are set to redefine security.

A new partnership uses Stan Lee's iconic image for charity, but can it overcome the ethical storms and financial pressures surrounding the legendary creator?

With a new FDA approval and a $400M market in sight, Citius Oncology faces a critical test: launching a potent lymphoma drug with a life-threatening risk.